Isolation of enterococci species causative of infections and sensitivity to antimicrobial drugs;Aislamiento de especies de enterococos causantes de infecciones y su sensibilidad a los antimicrobianos

Revista Argentina de Microbiologia

Volumn 36, Issue 1, 2004, Pages 31-35

  Toledo, C ^a   Perez, M E ^a   Rocchi, M ^a   Gribaudo, G ^a   Mangiaterra, S ^a   Monterisi, A ^a  

^a Universidad Nacional de Córdoba   (Argentina)

Author keywords

Antimicrobial susceptibility; Enterococcal infections

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; BETA LACTAMASE INHIBITOR; CHLORAMPHENICOL; DALFOPRISTIN PLUS QUINUPRISTIN; GENTAMICIN; IMIPENEM; STREPTOMYCIN; TEICOPLANIN; VANCOMYCIN;

ABSCESS; ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATION; DIABETIC FOOT; DRUG SENSITIVITY; ENTEROCOCCUS; ENTEROCOCCUS AVIUM; ENTEROCOCCUS CASSELIFLAVUS; ENTEROCOCCUS DISPAR; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ENTEROCOCCUS PSEUDOAVIUM; ENTEROCOCCUS RAFFINOSUS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; PERITONEAL CAVITY; SURGICAL WOUND; URINARY TRACT INFECTION;

ABSCESS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ARGENTINA; BODY FLUIDS; CROSS INFECTION; DIABETIC FOOT; DRUG RESISTANCE; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENTEROCOCCUS; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; IMIPENEM; MALE; MIDDLE AGED; SPECIES SPECIFICITY; SURGICAL WOUND INFECTION; TEICOPLANIN; URINARY TRACT INFECTIONS; VANCOMYCIN;

EID: 2442473818     PISSN: 03257541     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Berk SL, Verghese A, Holtsclaw SA, Smith JK (1983) Enterococcal pneumonia. Occurrence in patients receiving broad-spectrum antibiotic regimens and enteral feeding. Am. J. Med. 74: 153-154.
2. Cetinkaya Y, Falk P, Mayhall CG (2000) Vancomycin-resistant enterococci. Clin. Microbiol. Rev. 13: 686-707.
3. Chirurgi VA, Oster SE, Golberg AA, Zervos MJ, Mc Cabe RE (1991) Ampicilin-resistant Enterococcus raffinosus in an acute-care hospital: case-control study and antimicrobial susceptibilities. J. Clin. Microbiol. 29: 2663-2665.
4. th ed. American Society for Microbiology, Washington DC, p. 297-305.
5. Gordon S, Swenson JM, Hill BC, Pigott N, Facklam RR, Cooksey RC, et al (1992) Antimicrobial susceptibility patterns of common and unusual species of enterococci causing infections in the United States. J. Clin. Microbiol. 30: 2373-2378.
6. Grayson ML, Eliopoulos GM, Wennersten CB, Rvoff KL, Klimm K, Sapico FL, et al (1991) Comparison of Enterococcus raffinosus with Enterococcus avium on the basis of penicillin susceptibility, penicillin-binding protein analysis, and high-level aminoglycoside resistance. Antimicrob. Agents Chemother. 35: 1408-1412.
7. Gulberg RM, Homann SR, Phair JP (1989) Enterococcal bacteremia: analysis of 75 episodes. Rev. Infect. Dis. 11: 74-85.
8. Horvitz RA, von Graevenitz A (1977) A clinical study of the role of enterococci as sole agents of wound and tissue infection. Yale. J. Biol. Med. 50: 391-395.
9. Jett B, Huycke M, Gilmore M (1994) Virulence of enterococci. Clin Microbiol. Rev. 7: 462-478.
10. Louie M, Simor AE, Szeto S, Patel M, Kreiswirth B, Low DE (1992) Susceptibility testing of clinical isolates of Enterococcus faecium and Enterococcus faecalis. J. Clin. Microbiol. 30: 41-45.
11. Morris JF, Okies JE (1974) Enterococcal lung abscess: medical and surgical therapy. Chest 65: 688-691.
12. Murray BE, Lopardo A, Rubeglio EA, Frosolono M, Singh KV (1992) Intrahospital spread of a single gentamicina-resistant, b-lactamase producing strain of Enterococcus faecalis in Argentina. Antimicrob. Agents Chemother. 36: 230-232.
13. Murray BE (1990) The life and times of the enterococcus. Clin. Microbiol. Rev. 3: 46-65.
14. Murray BE (1992) β-lactamase-producing enterococci. Antimicrob. Agents Chemother. 36: 2355-2359.
15. Murray BE (2000) Vancomycin-Resistant Enterococcal Infections. N. Engl. J. Med. 342: 710-721.
16. 10 (M7). National Committee for Clinical Laboratory Standards, Wayne, Pa.
17. Reinert RR, Conrads G, Schager JJ, Werner G, Witte W, Lütticken R, Klare I (1999) Survey of antibiotic resistance among enterococci in North Rhine-Westphalia, Germany. J. Clin. Microbiol. 37: 1638-1641.
18. Ruoff KL, de la Maza L, Murtagh MJ, Spargo JD, Ferraro MJ (1990) Species identities of enterococci isolated from clinical specimens. J. Clin. Microbiol. 28: 435-437.
19. Struwig MC, Botha PL, Chalkley LJ (1998) In vitro activities of 15 antimicrobial agents against clinical isolates of South African enterococci. Antimicrob. Agents Chemother. 42: 2752-2755.
20. Toye B, Shymansky J, Bobrowska M, Woods W, Ramotar K (1997) Clinical and epidemiologic significance of enterococci intrinsically resistant to vancomycin (possessing the Van C genotype). J. Clin. Microbiol. 35: 3166-3170.
21. Vandamme P, Vercauteren E, Lammens C, Pensart N, leven M, Pot B, et al (1996) Survey of enterococcal susceptibility patterns in Belgium. J. Clin. Microbiol. 34: 2572-2576.
22. Wilke WW, Marshall SA, Coffman SL, Pfaller MA, Edmund MB, Wenzel RP, Jones RN (1997) Vancomycin-resistant Enterococcus raffinosus: molecular epidemiology, species identification error, and frequency of occurrence in a national resistance surveillance program. Diag. Microbiol. Infect. Dis. 29: 43-49.